Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 19856 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| carbidopa(UNII: MNX7R8C5VO) (CARBIDOPA ANHYDROUS - UNII:KR87B45RGH) | CARBIDOPA ANHYDROUS | 50mg | 25mg |
| levodopa(UNII: 46627O600J) (levodopa - UNII:46627O600J) | levodopa | 200mg | 100mg |
Inactive Ingredients
| Ingredient Name | Merck Sharp & Dohme Corp. |
|---|---|
| ALUMINUM OXIDE(LMI26O6933) | |
| FD&C BLUE NO. 2(L06K8R7DQK) | |
| FD&C RED NO. 40(WZB9127XOA) | |
| HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | |
| HYPROMELLOSE 2208 (3 MPA.S)(9H4L916OBU) | |
| INDIGOTINDISULFONATE SODIUM(D3741U8K7L) | |
| magnesium stearate(70097M6I30) |
